Meet InfiCure Bio at NLSDays April 20-23!
Make sure to book a one-on-one meeting with Dan Holmberg and/or Sofia Mayans, and take the opportunity to discuss the most recent data on the NIF mouse and learn how the model can help in [...]
Meet Dan Holmberg and learn more about the NIF mouse at the 3rd Annual CKD Summit March 2-4!
Dan Holmberg, CSO at InfiCure Bio, will participate at the 3rd Annual Chronic Kidney Disease (CKD) Summit March 2-4, hosted by Hanson Wade. Make sure to take the opportunity to meet with Dan, and learn [...]
Sofia Mayans participates in national pitching event 29th of January 2021
Sofia Mayans, CEO at InfiCure Bio, will participate in the national pitching competition "Hela Sverige Pitchar" by Connect Sverige. InfiCure Bio is one of 5 companies in Life Science/MedTech that will pitch on January 29 [...]
Pressrelease: InfiCure Bio secures US patent and publishes new data in a top scientific journal
https://www.mynewsdesk.com/se/umeaa-biotech-incubator/pressreleases/inficure-bio-secures-us-patent-and-publishes-new-data-in-a-top-scientific-journal-3060618?utm_source=rss&utm_medium=rss&utm_campaign=Alert&utm_content=pressrelease
New publication on the liver phenotype of the NIF mouse
Check out our new exciting study describing the liver phenotype of the NIF mouse! We are proud to announce that it has been accepted for publication in Scientific Reports (https://lnkd.in/emhf8h7). In this paper we demonstrate [...]
InfiCure Bio will attend the annual NASH Summit in mid December
InfiCure Bio AB will attend the 4th NASH Summit (https://nash-summit.com) in mid December and our CEO Sofia Mayans will give a talk on our unique NIF mouse on December 16th at 2.45pm EST. Do not [...]